Lista de obras - Rossana Maffei - Dominio Público Uruguay

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?

scientific article published on 26 November 2020

ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.

artículo científico publicado en 2013

Acute Myeloid Leukemia in Patients Living with HIV Infection: Several Questions, Fewer Answers

scientific article published on 06 February 2020

Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement

artículo científico publicado en 2017

Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status

artículo científico publicado en 2007

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

artículo científico publicado en 2010

Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis

scientific article published on 28 June 2008

Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance

artículo científico publicado en 2010

Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.

artículo científico publicado en 2012

Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study

article

Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor

artículo científico publicado en 2008

Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor

artículo científico publicado en 2014

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia

artículo científico publicado en 2013

Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features

article

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

artículo científico publicado en 2014

Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status

artículo científico publicado en 2006

IGHD3-3fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.

artículo científico publicado en 2016

Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers

artículo científico publicado en 2001

Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.

artículo científico publicado en 2009

Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis

artículo científico publicado en 2007

Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors.

artículo científico

Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.

artículo científico publicado en 2014

Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.

artículo científico publicado en 2013

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

artículo científico publicado en 2012

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

article

Mucorales-Specific T Cells in Patients with Hematologic Malignancies

artículo científico publicado en 2016

NOX-A12: mobilizing CLL away from home

artículo científico publicado en 2014

Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments

scientific article published on 22 January 2021

Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS

artículo científico publicado en 2019

Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis

artículo científico

Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

artículo científico publicado en 2011

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

artículo científico publicado en 2009

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

artículo científico publicado en 2005

Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib

artículo científico publicado en 2015

The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells

artículo científico publicado en 2013

The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

artículo científico publicado en 2013

Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines

artículo científico publicado en 2007

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

artículo científico publicado en 2009

Lista de obras de Rossana Maffei

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?

ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.

Acute Myeloid Leukemia in Patients Living with HIV Infection: Several Questions, Fewer Answers

Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement

Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis

Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance

Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.

Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study

Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor

Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia

Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status

IGHD3-3fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.

Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers

Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.

Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis

Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors.

Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.

Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

Mucorales-Specific T Cells in Patients with Hematologic Malignancies

NOX-A12: mobilizing CLL away from home

Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments

Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS

Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis

Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib

The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells

The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.